Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.66%
- Poor long term growth as Operating profit has grown by an annual rate 16.33% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
Flat results in Dec 25
Stock is technically in a Mildly Bearish range
With ROCE of 7.1, it has a Expensive valuation with a 4.5 Enterprise value to Capital Employed
Stock DNA
Telecom - Equipment & Accessories
INR 62 Cr (Micro Cap)
45.00
22
0.00%
0.13
7.13%
1.93
Total Returns (Price + Dividend) 
Latest dividend: 0.1 per share ex-dividend date: Sep-16-2011
Risk Adjusted Returns v/s 
Returns Beta
News

Telogica Ltd is Rated Strong Sell
Telogica Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Broad-Based Technical Strength Lifts Telogica Ltd to 52-Week High of Rs 15.88
Surging past its previous peaks, Telogica Ltd reached a new 52-week high of Rs 15.88 on 23 Apr 2026, marking a remarkable 39.9% gain over the past year despite a broadly negative market backdrop. This milestone reflects a strong alignment of technical indicators and sustained price momentum that has propelled the micro-cap telecom equipment stock well above its 52-week low of Rs 8.
Read More
Telogica Ltd is Rated Strong Sell
Telogica Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read More Announcements 
Newspaper Publication Of The Audited Standalone Financial Results For The Fourth Quarter And Financial Year Ended March 31 2026
30-May-2026 | Source : BSENewspaper Publication of the Audited Standalone Financial Results for the Fourth Quarter and Financial year ended March 312026.
Statement Of Utilization Of Funds And Statement Of Deviation / Variation In The Use Of Proceeds Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter And Financial Year Ended 31St March 2026.
29-May-2026 | Source : BSEStatement of utilization of funds
Disclosure Of Related Party Transactions For The Fourth Quarter And Financial Year Ended 31St March 2026.
29-May-2026 | Source : BSEDisclosure of Related Party transaction as per Reg.23(9) of SEBI (LODR) regulation 2015
Corporate Actions 
No Upcoming Board Meetings
Telogica Ltd has declared 2% dividend, ex-date: 16 Sep 11
Telogica Ltd has announced 5:10 stock split, ex-date: 24 Feb 10
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Srinivasa Rao Mandava (17.51%)
Logiclinx Corporation (15.31%)
36.16%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 89.45% vs 66.23% in Mar 2025
YoY Growth in quarter ended Mar 2026 is 100.00% vs 119.28% in Mar 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 8.64% vs 72.46% in Sep 2024
Growth in half year ended Sep 2025 is -70.09% vs 3,466.67% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 53.89% vs -11.95% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -62.60% vs -63.06% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 68.00% vs 7.95% in Mar 2025
YoY Growth in year ended Mar 2026 is -15.88% vs 102.38% in Mar 2025